This inventor holds 1 USPTO granted patent. Top assignee: Jenapharm Gmbh & Co. Kg. Active years: 2003.
Company Filing History:
Years Active: 2003
Title: The Innovative Contributions of Adolf Eduard Schindler
Introduction
Adolf Eduard Schindler is a notable inventor based in Essen, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the administration of dienogest for medical purposes. His innovative approach has led to advancements in treatments related to breast health.
Latest Patents
Schindler holds a patent for a method of administering dienogest in high dosages to reduce the body of the breast. This patent describes a method for administering dienogest to women in dosages that are at least ten times the effective dosage for inhibiting ovulation. The pharmaceutical composition associated with this method is designed to promote the retrogression of mastopathic changes in the breast. Furthermore, dienogest has been identified as highly effective in preventing the formation of mastopathic changes when administered in high dosages.
Career Highlights
Adolf Eduard Schindler is associated with Jenapharm GmbH & Co. KG, where he has been able to apply his innovative ideas in a practical setting. His work has contributed to the development of new pharmaceutical solutions that address women's health issues.
Collaborations
Some of Schindler's notable coworkers include Michael Oettel and Bernd Christensen. Their collaborative efforts have likely played a role in the successful development of his patented methods and compositions.
Conclusion
Adolf Eduard Schindler's contributions to the field of pharmaceuticals, particularly through his patent on dienogest administration, highlight his innovative spirit and dedication to improving women's health. His work continues to influence the medical community and offers promising solutions for breast health issues.